10x Genomics, Inc., a leader in single cell and spatial biology, announced it had secured a permanent injunction in the US District Court for the District of Delaware against the GeoMx products sold ...
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company specializing in innovative cell therapy platforms for cancer, autoimmune, and infectious diseases, announces the completion of its ...
Kaneka Corporation, is a Japanese international chemical manufacturing company, won its lawsuit against Designs for Health, Inc. and American River Nutrition, LLC for their infringement of Kaneka’s US ...
Meiji Seika Pharma Co., Ltd., a pharmaceutical company that develops, manufactures, and sells a range of products, announced the establishment of a local subsidiary, “Taiwan Meiji Pharma Co., Ltd.”, ...
US FDA approves AVITA Medical’s RECELL GO mini disposable cartridge to treat smaller wounds: Valencia, California Friday, December 27, 2024, 18:00 Hrs [IST] AVITA Medical, Inc., ...
Intuitive brings global experts to India to train general surgeons in advanced robotic surgery: Our Bureau, Bengaluru Friday, December 27, 2024, 17:25 Hrs [IST] Intuitive, a globa ...
Our Bureau, Mumbai Friday, December 27, 2024, 17:15 Hrs [IST] Dr Sandip Shah has taken over as chairman of the National ...
Digital health innovations reshaping patient engagement discussed at IHW Summit: Our Bureau, Mumbai Friday, December 27, 2024, 16:50 Hrs [IST] The 3rd Patient First Summit, hosted ...
Bio-Thera Solutions partners with Tabuk Pharma to commercialize BAT2206, a Stelara biosimilar in Saudi Arabia: Guangzhou, China Friday, December 27, 2024, 15:00 Hrs [IST] Bio-Ther ...
Waters Corporation named to Dow Jones Sustainability Index for the fourth consecutive year: Our Bureau, Bengaluru Friday, December 27, 2024, 14:40 Hrs [IST] Waters Corporation ann ...
Ractigen Therapeutics begins patient dosing in phase I trial of RAG-17 in SOD1-ALS: Nantong, China Friday, December 27, 2024, 12:00 Hrs [IST] Ractigen Therapeutics, a clinical-sta ...
AstraZeneca, Daiichi Sankyo voluntarily withdrawn the MAA in the EU for datopotamab deruxtecan for patients with locally advanced or metastatic NSCLC: Cambridge, UK Friday, Decemb ...